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Abstract
Background: Medically unexplained loss or alteration of voice—functional dysphonia—is the commonest presentation
to speech and language therapists (SLTs). Besides the impact on personal and work life, functional dysphonia is
also associated with increased levels of anxiety and depression and poor general health. Voice therapy delivered
by SLTs improves voice but not these associated symptoms. The aims of this research were the systematic development
of a complex intervention to improve the treatment of functional dysphonia, and the trialling of this intervention for
feasibility and acceptability to SLTs and patients in a randomised pilot study
Methods: A theoretical model of medically unexplained symptoms (MUS) was elaborated through literature review and
synthesis. This was initially applied as an assessment format in a series of patient interviews. Data from this stage and a
small consecutive cohort study were used to design and refine a brief cognitive behavioural therapy (CBT) training
intervention for a SLT. This was then implemented in an external pilot patient randomised trial where one SLT delivered
standard voice therapy or voice therapy plus CBT to 74 patients. The primary outcomes were of the acceptability of the
intervention to patients and the SLT, and the feasibility of changing the SLT’s clinical practice through a brief training.
This was measured through monitoring treatment flow and through structured analysis of the content of intervention
for treatment fidelity and inter-treatment contamination.
Results: As measured by treatment flow, the intervention was as acceptable as standard voice therapy to
patients. Analysis of treatment content showed that the SLT was able to conduct a complex CBT formulation
and deliver novel treatment strategies for fatigue, sleep, anxiety and depression in the majority of patients.
On pre-post measures of voice and quality of life, patients in both treatment arms improved.
Conclusion: These interventions were acceptable to patients. Emotional and psychosocial issues presented
routinely in the study patient group and CBT techniques were used, deliberately and inadvertently, in both
treatment arms. This CBT “contamination” of the voice therapy only arm reflects the chief limitation of the
study: one therapist delivered both treatments.
Trial registration: Registered with the ISRCTN under the title: Training a Speech and Language Therapist in
Cognitive Behavioural Therapy to treat Functional Dysphonia - A Randomised Controlled Trial.
Trial Identifier: ISRCTN20582523 Registered 19/05/2010; retrospectively registered. http://www.isrctn.com/
ISRCTN20582523
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Background
Whilst the classification and nomenclature of voice dis-
orders remain disputed [1], “functional dysphonia” can
be used (and is used here) to denote an alteration or loss
of voice in the absence of an organic disorder, or where
the observed pathology is insufficient to explain the
vocal symptoms. Thus defined, functional dysphonia is
the commonest disorder presenting to UK voice clini-
cians, accounting for up to 40,000 new cases per year
[2]. It is known to affect communication in all contexts
and is related to impaired personal and work relation-
ships, low self-esteem and reduced quality of life [3]. In
addition, people with functional dysphonia also suffer
from increased levels of anxiety, depression and poor
general health [4, 5]. Voice therapy, delivered by speech
and language therapists, has been shown to improve
voice quality in functional dysphonia patients, but there
is no evidence to date of any effect on their more gen-
eral well-being [6]. The aim of our research programme
was to develop and pilot a new psychosocial intervention
aimed at improving both voice and well-being in this pa-
tient group.
As defined above, functional dysphonia can be classi-
fied as a medically unexplained symptom (MUS) [1].
MUS in the absence of physical pathology form a con-
siderable health care burden, with around 50% of refer-
rals in specialist clinics being in some way medically
unexplained [7]. For many medically unexplained condi-
tions, there is evidence for the effectiveness of cognitive
behavioural therapy (CBT), a multi-component complex
intervention involving a mixture of changing behaviours,
such as symptom lead patterns of activity avoidance, and
changing beliefs, such as catastrophic interpretation of
symptoms [8]. In attempting to improve both the treat-
ment and understanding of functional dysphonia, it
seems appropriate to employ theoretical and clinical in-
sights derived from previous applications of a CBT
model in other MUS to this speech disorder.
The application of the CBT model to these other con-
ditions has been successful to the extent that many
MUS have been to some degree explained, and im-
proved, as has their co-morbid distress [9]. Initially, the
therapy was typically delivered by highly specialised pro-
fessionals trained in psychiatry, clinical psychology or
cognitive behavioural therapy. Recently, with a view to
making this type of therapy more widely available in a
cost-effective manner, there has been a move to training
non-specialists such as nurses and allied health profes-
sionals to deliver CBT. For example, there have been at-
tempts to improve patient outcomes in diabetes and
irritable bowel syndrome through training practice
nurses in CBT [10, 11].
In a review of the nature and treatment of functional
dysphonia [12], Baker states that the training of speech
and language therapists to assess and treat the psy-
chosocial issues associated with functional dysphonia is
a “ethical and professional obligation” ([12] page 103).
We therefore aimed to develop, in several stages, a
CBT intervention for delivery by speech and language
therapists (thus requiring professional behaviour
change) and then to test its feasibility and acceptability
in an external pilot randomised controlled trial, com-
paring the speech and language therapist (SLT)-deli-
vered CBT to usual care.
A behaviour change intervention delivering CBT tech-
niques to a patient presenting with a physical problem
constitutes a “complex intervention”; it is complex both
by virtue of the multi-component nature of the interven-
tion and by the intended mode of delivery—the training
of a health professional. As several authors have noted
[13–15], there is surprisingly little evidence or consensus
around the development and evaluation of complex in-
terventions, particularly regarding the earlier develop-
mental stages. To address this, the Medical Research
Council (MRC) published guidelines [15] in a model
which acknowledges the iterative, cyclical nature of the
process (see Fig. 1).
In the development phase, the theoretical and empir-
ical grounds of the intervention need to be established.
Typically, this involves a review of the evidence base and
an identification or development of the underpinning
theory for the intervention. In the field of behaviour
change research, there is increasing emphasis on the im-
portance of basing interventions on theory [13, 16].
There is however less consensus, and little evidence, for
what should happen in the modelling phase, where the
nature of the behaviour change intervention is specified.
Suggested methods include evidence review, patient in-
terviews (group and individual) and expert consultations
[13, 14, 17]. The present paper describes a systematic, it-
erative process of intervention development which is
theoretically based, patient centred and guided by the
MRC framework from modelling through to piloting.
Methods
Stage 1: development
Theory selection.
The first step in the identification of a theory and a the-
oretical model was a comprehensive review of the litera-
ture of explanatory processes and models of MUS in
general [9]. This process identified a general explanatory
model of functional symptoms as having predisposing,
precipitating and perpetuating factors. The perpetuating
factors included physical, behavioural, cognitive, affective
and social components. This expanded CBT model of
MUS [9] formed the theoretical basis of the current
study of FD patients.
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Model building
Next, the literature on predisposing, precipitating and
perpetuating factors in functional dysphonia was
reviewed in the context of the expanded CBT model of
MUS. Evidence was found for predisposing vulnerabil-
ities (gender, personality, occupation, other MUS); pre-
cipitating triggers (life events, viruses) and perpetuating
factors (dysregulation of the laryngeal and paralaryngeal
muscles, anxiety and depression) (for full review see [1].
Model development—patient interviews
Eight patients with functional dysphonia were interviewed
by one member of the team (VD, a cognitive behavioural
therapist) using an assessment structure based on the ex-
panded CBT model identified above. This was used to
elicit as wide a range of predisposing, precipitating and
perpetuating factors of patients’ problems as possible.
Individualised formulations, describing the interaction of
multiple factors in the onset and maintenance of func-
tional dysphonia and its associated distress, were worked
out in session in collaboration with patients.
Initial development and delivery of the intervention.
Common factors, themes and patterns of interaction
identified from the patient interviews and formulations
as being important in the causation and maintenance of
functional dysphonia were used alongside the theory and
modelling data to develop an individually adaptable, ex-
panded CBT model of functional dysphonia. This
formed the basis of the speech and language therapist
training package. This training was initially piloted in a
small consecutive cohort study [18].
Refinement of the functional dysphonia model
Two notable further insights were gained through clin-
ical supervision during this small cohort study and
through discussion with speech and language therapists.
Functional dysphonia patients routinely reported ex-
haustion, with disturbed patterns of activity, rest and
sleep. They also tended to report perfectionist tenden-
cies. This leads to a questionnaire-based case-control
study into these aspects of dysphonia, which confirmed
that this group was significantly more fatigued and per-
fectionist than matched normal controls [19]. This fur-
ther shaped the CBT model and training.
Assessing and maximising the likelihood of intervention
uptake
The prior consecutive cohort study [18] provided evi-
dence that, for at least one speech and language therap-
ist, delivering the CBT was feasible and acceptable. To
further tailor the training for the generic and specific
context in which it was to be implemented, VD carried
out interviews with individual therapists, clinical teams
and a voice special interest group. This process gave an
understanding of how presenting problems other than
voice issues (particularly anxiety, depression and person-
ality problems) were routinely dealt with by SLTs in their
Fig. 1 The Medical research council framework for complex intervention development
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management of functional dysphonia patients. Next, the
SLT to be trained to deliver the CBT intervention (TM)
was interviewed, to establish training needs, learning
style and normal practice in the management of func-
tional dysphonia and to establish a protocol for how
emotional issues were to be dealt with in the usual care
randomised controlled trial (RCT) arm.
Stage 2: feasibility—an external pilot randomised
controlled trial
As a preliminary, a further set of patient interviews were
conducted with greater attention to factors highlighted
in the initial intervention development stages. These in-
terviews confirmed the findings on perfectionism, fa-
tigue, disordered activity, rest and sleep. Furthermore,
the interviews supported the feasibility of addressing
these with patients through developing a shared multi-
factorial understanding of their condition. The insights
gained from the above stages were used to further refine
the model, the training of the therapist and the design
and conduct of the pilot RCT. The objectives of this trial
were as follows:
Acceptability and feasibility objectives
 To assess the feasibility and acceptability of
procedures and methods for trial participant
identification, recruitment and data collection.
 To assess the feasibility and acceptability of the
CBT intervention to a SLT by evaluating their
ability to integrate CBT training into clinical
practice and by evaluating the amount and nature
of supervision required to embed the CB
intervention in usual care.
 To assess the fidelity of delivery, acceptability and
clinical utility of a CBT intervention to functional
dysphonia patients.
 To test the sensitivity to change of a selection of
candidate outcome measures
These objectives were measured and monitored
through recruitment and retention rates (patient accept-
ability of intervention and trial procedures), through ob-
servation of the training process (therapist acceptability)
and through monitoring the process and content of the
CBT participants’ treatment, in clinical supervision, case
recordings, case notes and case summaries (fidelity, ther-
apist and patient acceptability and feasibility, clinical
utility). The main outcomes were the feasibility and ac-
ceptability estimates, assessed as described above. In
addition, measures were taken of voice (Voice Perform-
ance Questionnaire, Carding et al. 1999), general health
(General Health Questionnaire, Goldberg and Williams
1988) and psychological distress (Hospital Anxiety and
Depression Scale Zigmond and Snaith, 1983, at baseline,
at discharge from treatment (usually 6–8 sessions hap-
pening every other week) and 6 months after the end of
treatment. These outcomes were assessed with regard to
their acceptability and responsiveness to change, to as-
sist in powering a future trial and will be the subject of a
separate paper.
Design
The trial was a single-centre external pilot, patient ran-
domised controlled trial with two arms: standard voice
therapy versus voice therapy plus CBT, both delivered by
a single SLT (TM), experienced in treating functional
dysphonia.
The study was conducted at the Speech Voice and
Swallowing Clinic of the Freeman Hospital, Newcastle
upon Tyne, UK, between October 2007 and August
2010. Participants who remained in treatment or follow-
up after this point continued to receive fully supervised
treatment. Ethical permission was sought and obtained
from Newcastle and North Tyneside Research Ethics
Committee 1 (ethics reference number: 07/H0906/118).
The trial was registered with the ISRCTN under the
title: Training a Speech and Language Therapist in Cog-
nitive Behavioural Therapy to treat Functional Dyspho-
nia - A Randomised Controlled Trial. Trial Identifier:
ISRCTN20582523.
Inclusion/exclusion criteria
Study participants were patients who had been referred to
the Speech and Voice Clinic, for assessment of their dys-
phonia. Patients were screened by endoscopy, which ex-
cluded the presence of an injury, a lesion or a movement
disorder in the patient’s voice box. Patients who had been
thus diagnosed as having functional dysphonia were
approached regarding entry into the trial. They were given
participant information sheets describing the study in de-
tail and at least 24 h to consider participation.
For the sake of generalisability, inclusion criteria were
as broad as possible. Patients were considered eligible
for randomisation if they were aged 18 or over and pre-
sented with an alteration or loss of voice where there
was no evidence of a non-functional reason for vocal
impairment (other than vocal nodules), a score of ≥ 1 on
the overall Grade component of the clinician-rated voice
quality Grade Roughness Breathiness Asthenia Strain
Scale (GRBAS) [20] and a score of ≥ 20 on the self-rated
Vocal Performance Questionnaire (VPQ) [21] (a self-
report measure of voice quality and voice related disabil-
ity rated 12–60 with 12 being normal). Patients were
excluded from the trial if they had any of the following:
previous experience of CBT for their voice problem; an
acute or ongoing serious medical illness or severe mental
health problem which was likely to interfere with their
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ability to comprehend, engage and/or comply with treat-
ment; a learning disability; and a mild vocal condition
which did not merit a full course of treatment.
Interventions—usual care: voice therapy
The control condition of “usual care” aimed to be as
close to standard voice therapy practice as possible. Pa-
tients were offered an average of six to eight sessions
every 2 weeks of approximately 1 h of voice therapy, al-
though length and number of sessions were allowed to
vary as needed. The content typically had the following
elements: vocal hygiene and education (such as main-
taining adequate vocal hydration); elimination of voice
misuse and abuse (such as excessive throat clearing or
shouting); breath control and coordination with phon-
ation; and in-session and between-session exercises to
promote vocal flexibility and resonance. When emo-
tional issues arose in the course of therapy sessions, the
SLT employed non-directive counselling skills, whereby
patients were encouraged to speak about difficult issues,
reflecting TM’s normal pre-CBT practice.
Interventions—the CBT intervention
In the experimental CBT arm, in addition to the stand-
ard voice therapy, patients also received the following
CBT elements. As with usual care, treatment sessions
lasted approximately 1 h.
Assessment and formulation
The CBT assessment identified the predisposing, pre-
cipitating and perpetuating factors. It was derived from
the CBT model of functional dysphonia previously de-
scribed. This information formed the basis of a formu-
lation that attempted to explain how current factors
might be interacting to maintain both poor voice and
general distress, and how these had developed through
the interaction of predisposing and precipitating fac-
tors. This formulation formed the basis for both treat-
ment delivery (by TM) and treatment supervision (by
VD). The ability to reach an agreed formulation with
the patient was also a key measure of the acceptability
of CBT for the patient group.
Treatment techniques
As each patient had an individualised formulation, no
two treatments were identical, but they typically con-
sisted of a mixture of the following treatment tech-
niques. For low energy and low mood, patients were
advised gradually to do more, in a structured planned
way, and gradually to resume activities that used to be
done for enjoyment and achievement. These evidence-
based methods [22] are relatively simple and hence eas-
ily transmissible from trainer to therapist and from ther-
apist to patient. Graded exposure was used to address
anxiety-based issues [23]. People who are anxious tend
to avoid what they are anxious of (and thus become
more anxious) encouraging people to gradually confront
difficult situations in a planned and structured way and
at their own pace is the best evidence-based treatment
[23]. This work also incorporated simple cognitive tech-
niques, such as helping the patient identify what kind of
anxious thoughts they might be having about avoided
situations and helping them to test out the reality of
these thoughts by confronting the situation in a safe,
planned manner. Cognitive work was thus conceptua-
lised as being an adjunct and aide to behavioural change.
In addition, the therapist was trained in specific cogni-
tive techniques for the negative aspects of perfectionism
such as very high self-standards and self-criticism [24].
Other common unhelpful beliefs concerned the best way
to manage voice and other physical symptoms, with pa-
tients often interpreting symptoms as harmful and as a
cue to stop activity and to socially withdraw, thus keep-
ing going a cycle of physical dis-use, low energy and low
mood. Cognitive techniques, such as guided questioning
during therapy sessions and thought diaries in between
sessions, helped patients to identify their unhelpful be-
liefs and test them out by looking for evidence both for
and against them.
These assessment and treatment techniques were
taught to TM over a total of 7 days, over a 2-week
period, by VD, with extensive use of skills rehearsal and
supported by a full training manual. Patient implementa-
tion was supported with a patients’ manual, outlining
each of the above approaches, with examples.
Monitoring and supervision
All treatment sessions were recorded using digital audio
equipment. All patients in the CBT arm were reviewed
weekly using a CBT supervision framework where the
individualised formulation formed the basis for case dis-
cussions between TM and VD. TM’s management of
those randomised to usual care (voice therapy alone)
was supervised as usual by PC (another experienced
speech and language therapist). To monitor for the in-
trusion of CBT techniques into usual care, TM identified
patients in this cohort where distress was an issue and
VD listened to recorded sessions and asked her to de-
scribe her treatment approach. Detailed clinical notes
were also kept by TM of session content for both arms
of the trial. These provided content for supervision and
allowed the performance of fidelity, feasibility and ac-
ceptability analyses of the intervention for both partici-
pants and therapist.
Sample size
As this was an external pilot RCT, the primary deter-
minant of the sample size was pragmatic, i.e. the
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throughput of the unit over the period of the trial. No
formal power calculation was used but the guideline of
Lancaster et al. [25] was followed which suggests that
in an external pilot trial, 30 patients per arm may be
sufficient to estimate the parameters of interest for a
larger trial. Factoring in estimates of likely non-
suitability, we anticipated being able to recruit this
number over 18 months. We continued to recruit up to
this latter time-point, resulting in 74 patients rando-
mised to the study.
Randomisation, allocation concealment and blinding
Once a patient consented, they were randomly allocated
either to voice therapy alone or voice therapy plus CBT.
An independent researcher at Newcastle Clinical Trials
Unit prepared a randomisation list, using permuted
blocks of random sizes to reduce risk of breach of con-
cealment of allocation. Sequentially numbered, opaque
envelopes were prepared and provided to the clinic. The
randomisation envelope was opened by the speech and
language therapist in the presence of the patient follow-
ing receipt of written consent. Patient details, date and
time of randomisation were recorded, to maintain an
audit trail of randomisation. Neither participant nor the
therapist (TM), who was also responsible for data collec-
tion, nor the researcher responsible for data analysis
(VD) was blind to treatment allocation.
Data analysis and use
Data were analysed in the following stages. Rates of re-
cruitment, retention and protocol violations were ana-
lysed with respect to the feasibility and acceptability of
the interventions from patient and therapist standpoints.
Success of randomisation was assessed by informally
comparing both groups’ baseline characteristics. A tally
of problem formulations, treatment targets and treat-
ment techniques was done in the CBT group to assess
the feasibility of transmitting CBT techniques to an SLT,
and the acceptability of CBT techniques to patients. A
tally was also done of the content of any voice therapy
only sessions where emotional issues formed a signifi-
cant part of the work.
Full trial protocol is available [26].
Results
The following is reported to the extended CONSORT
guidelines for reporting pilot and feasibility studies [27].
Feasibility and acceptability
We judged the feasibility and acceptability of the inter-
vention according to the following criteria: comparable
rates of drop-out between both trial arms (patient ac-
ceptability); evidence of a CBT formulation being pos-
sible for the majority of clients in the CBT arm (clinician
and patient acceptability); evidence of CBT treatment
strategies for the majority of clients in the CBT trial arm
(clinician and patient acceptability). Evidence of sensitiv-
ity to change in candidate outcome measures (question-
naire acceptability).
Treatment flow
One hundred seventy-five patients were referred by GPs
or consultants to the Speech and Voice Clinic of the
Freeman Hospital, over the recruitment period of the
trial (October 2007–September 2009). Of the 175 that
were referred, 7 did not attend their appointments so
168 (96% of referrals) were assessed for eligibility. Of
these, 64 (38% of those screened) did not fulfil the inclu-
sion criteria: 46 were only mildly dysphonic, i.e. their
GRBAS Grade item score was less than 1 and/or their
VPQ score was less than 20. A further ten had other
voice disorders: six were unspecified, two had spasmodic
dysphonia, one had puberphonia and one had a vocal
cord cyst. Three had a serious medical complaint and
three had a serious mental health issue. One had insuffi-
cient English and one was under 18 years old. The rate
of eligibility amongst those assessed was therefore 62%
(104/168). Of those who were apparently eligible, a fur-
ther 30 (29%; 30/104) did not consent to be randomised.
Of these, two were in psychotherapy and four had had
recent psychotherapy; two did not like the idea of psy-
chotherapy; one could not commit to the time involved
in therapy; one had too far to travel and one had an on-
going complaint against the NHS Trust. Nineteen did
not give a reason. The remaining 74 patients (71% of
those eligible) were recruited to the trial; 37 were rando-
mised to each treatment group. These were the figures
originally intended (see Fig. 2).
Considering drop outs from treatment as a measure of
treatment acceptability/feasibility, there were 4/37
(10.8%) in the CBT group and 4/37(10.8%) in the SLT
group. At the 6-month follow-up, a further five patients
did not attend the appointment or return questionnaires
in the CBT group; an additional one patient did not at-
tend appointment or return questionnaires in the usual
care group. Thus follow-up attrition was 24.3% for CBT
and 13.5% for usual care. Reasons for this will be consid-
ered in the “Discussion”.
Protocol adherence and violations
Both protocol adherence and violations were monitored
on an on-going basis through clinical supervision of the
SLT’s case load, audio recordings of sessions and case
notes.
An individualised CBT formulation was possible with,
and acceptable to, 32 out of 37 participants (86.5%). Of
the five where formulation was not possible, three re-
ported dysphonia as their sole problem with general
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mental and physical health being otherwise good. These
three participants received voice therapy only. The
fourth participant reported a co-morbid anger manage-
ment problem, already being managed by medication,
and also received voice therapy only. Thus, four partici-
pants in the CBT arm received voice therapy only. One
further patient allocated to the CBT group dropped out
early in treatment before the feasibility of a formulation
could be determined. There were three other notable
cases in the CBT group. One participant was severely
depressed and required joint sessions delivered by the
SLT (TM) with the CBT supervisor (VD), in liaison with
their general practitioner. One participant contracted tu-
berculosis and required a long mid treatment break.
One participant, whose anxiety disorder had been
responding well to CBT, suffered a relapse following a
violent trauma in her family and needed an extended
treatment course over the following 18 months.
In the SLT group, three dropped out after the first ses-
sion. Nine participants (24%; 9/37) had emotional issues
which formed a substantial part of the treatment plan;
for seven (18.9%), there was either notable CBT influ-
ence in SLT treatment sessions or the patient received
other psychological intervention (by another health pro-
fessional) external to the pilot trial. This “contamination”
or co-intervention will be discussed further below.
Baseline data
Table 1 shows the baseline characteristics of the groups
and also the mean number of sessions in each of the treat-
ment arms. Groups were well matched on most cha-
racteristics at baseline, demonstrating the success of
randomisation. Demographically, there were twice as
many men in the SLT group than in the CBT group, but
proportions were small in both groups (16.2 and 8.1% re-
spectively). There were more professional voice users, e.g.
teachers, call centre workers and counsellors, in the SLT
(62.2%) group than in the CBT group (37.9%). Some mea-
sures were missing at baseline, thus N varies in the table.
On all baseline outcome scores, patients in both
arms were comparable. The mean General Health
Questionnaire-28 scores [28] of participants in each
Fig. 2 Treatment flow
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arm exceeded the caseness threshold; 56.8% of partici-
pants in each arm had General Health Questionnaire
(GHQ)-28 scores equalling or exceeding the caseness
threshold of 22. On Hospital Anxiety And Depression
Questionnaire (HAD) [29] measures of anxiety and
depression, where the caseness cut-off is 8 for both
factors, the mean of both groups was clinically signifi-
cant on anxiety only. The percentages clinically anx-
ious were 56.8 and 51.3% in the SLT and CBT arms
respectively. Mean HAD depression scores fell below
the caseness threshold with 32.4% being cases in the
SLT arm and 29.7% in the CBT arm. Mean fatigue
levels were higher than the general population norm
(13.72, 95% CI 13.65–13.79) [30] in both groups. The
numbers of sessions of therapy received were compar-
able. In terms of impact of baseline scores, although
numbers were too small to establish significance,
there was an interesting trend. Participants with
higher scores in vocal disability tended to drop out of
the SLT arm, and participants with lower measures of
anxiety, depression and fatigue tended to drop out of
the CBT arm.
CBT treatment content and fidelity as measures of
treatment acceptability and feasibility
Fidelity of delivery, feasibility and acceptability to pa-
tients of the CBT intervention was assessed by monitor-
ing the content of the sessions via real-time clinical
supervision and retrospective content analysis of TM’s
contemporaneous case notes. As mentioned above, CBT
case formulation was feasible in 32 out of the 37 cases
(86%) with the exceptions being mostly “pure” voice dis-
orders. The acceptability and feasibility for participants
(and by implication also for the SLT) were further ana-
lysed by assessing in what proportion of participants it
was possible to identify the main hypothesised targets
for CBT treatment, and in what proportion of partici-
pants CBT techniques were attempted.
Fatigue was identified as a clinical issue in 27 (72.9%)
of the participants in the CBT arm. Of these, 20 (74.1%)
attempted graded activity interventions, the main
evidence-based intervention for fatigue. Of the seven
who did not, four were treatment drop outs and two
chose only to engage with the voice therapy aspects of
treatment. One participant did discuss the general prin-
ciples of graded activity but, unlike the others, did not
keep diaries or set targets. This more discursive ap-
proach was classified as generic counselling in our feasi-
bility analysis, being closer in content to the SLT’s pre-
existing clinical skills. Sleep problems, mainly in sleep
onset and/or maintenance, were a clinical issue for 25
participants (67.6%). Of these, 18 (72%) attempted sleep
management strategies. As with fatigue, of the seven
who did not attempt sleep management strategies, four
were treatment drop outs, two engaged only in voice
therapy and one discussed principles without formally
applying them.
Low mood was identified as a clinical issue for 23
(62.2%) participants in the CBT arm. Of these, 14 (60.9%)
attempted the CBT intervention of behavioural activation.
Of the nine who did not, four were treatment drop outs,
four dealt with mood though general emotional expres-
sion which is again classed as counselling and one did not
engage with the CBT aspects of treatment.
Anxiety and/or worry was identified as a clinical issue
for 20 (54.1%) participants in the CBT arm. Of these, 14
(70%) used a behavioural or cognitive approach to their
anxious thoughts. Of the six who did not, three were
treatment drop outs, two took a more general counsel-
ling approach and one did not engage with CBT. Two
further participants identified anger as their main emo-
tional issue; one dropped out and the other was receiv-
ing medication and chose not to deal with the anger
issues through CBT.
As previously suggested by O’hara [19], perfectionism
was also a significant factor in the onset and/or
Table 1 Baseline characteristics of the two arms of the pilot RCT
N SLT only Caseness N(%) N CBT Caseness N(%)
Age 37 45.8(13.5) 37 43.5 (16.3)
Male 6 (16.2%) 3(8.1%)
Female 31(83.8%) 34(91.9%)
Voice user 23(62.2%) 14(37.9%)
Measures Mean(sd) Mean(sd)
GRBAS 37 1.6(0.7) 37 1.8(0.8)
HAD Depression 31 5.3(4) 12(39%) 34 6.5 (4.2) 11(32%)
VPQ 37 31 (7.9) 36 33.4 (8.9)
HAD Anxiety 31 8.4 (4.7) 21(68%) 34 8.9(4.4) 19(56%)
GHQ-28 32 29.4(13.6) 21(66%) 34 28.1(14.3) 21(62%)
Sessions 6.2(4.1) 7.5(4.1)
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maintenance of dysphonia (i.e. a precipitating or per-
petuating factor) in a number of patients in this pilot
trial. This was borne out by the treatment formulations.
Of the 32 CBT formulations, 17 (53.1%) reported either
perfectionism or high self-standards as factors involved
in the onset or maintenance of the patient’s problems.
Clinically, perfectionism was treated in variety of ways:
setting behavioural targets that were not determined by
high self-standards; fostering an attitude of self-
compassion; cognitive work on “all or nothing” thinking
or general counselling skills.
Overall, this content analysis of sessions suggested
that CBT treatment was both feasible with, and accept-
able to, the majority of participants. By implication, it
was also feasible and acceptable to the therapist who
was delivering it. This aspect was monitored through
case discussion and through listening to audio record-
ings of CBT sessions and using these as the basis for
supervision sessions. Case formulations, treatment tar-
gets and treatment rationales were all appropriately
employed in all eligible cases. The training took an ini-
tial 7 days, and supervision was then weekly for the first
year of the trial, becoming every other week and then
as needed as the trial progressed and the SLT’s confi-
dence increased. This totalled to approximately 120 h
of face to face time between supervisor and therapist
over the span of the trial, not including the time taken
to prepare and read materials and listen to and reflect
on sessions.
Clinical utility
For the purposes of this feasibility study, no formal
between-group differences are reported. However, what
was clear was that at the 6-month follow-up point, there
was an effect for both treatment arms (the following fig-
ures being for those with complete data at baseline and
6 months). In terms of distress, mean HAD depression
scores went from 5.16(sd4.12) to 2.12(sd2.83) in the SLT
arm and from 7.08(sd4.5) to 2.69(sd2.83) in CBT arm.
Mean GHQ-28 scores went from 29.41(sd14.67) to
14(sd5.61) in the SLT arm and from 30.22(sd15.67) to
16.73(11.04) in the CBT arm. In terms of voice, VPQ
scores went from 29.08(sd6.36) to 17.68(sd5.01) in the
SLT arm and from 35.28(sd11.42) to 16.77(sd6.53) in the
CBT arm. This would suggest that both treatments had a
positive effect on voice and distress. However, the utility
of the SLT only intervention for distress must be consid-
ered in the context of the evidence for CBT co-
intervention in the SLT only arm. This is further discussed
below. Overall, the use of these candidate outcome mea-
sures proved that they are sensitive to change using this
intervention for this condition and that they would be
suitable for use in a future trial.
Discussion
This is the first trial to provide feasibility and accept-
ability data on a cognitive behavioural intervention for
functional dysphonia. The data indicates that the trans-
mission of CBT skills to a speech and language therap-
ist was possible and further that the intervention had
an impact on the conduct and content of the sessions
with patients.
Feasibility and acceptability
As indicated by recruitment and drop out
There was a relatively low refusal rate. Of the 104 who
were suitable for randomisation, 30(29%) did not con-
sent to be randomised. This would suggest that the idea
of the intervention was acceptable to the majority of pa-
tients. Only two gave the content of the intervention as
the reason for not wishing to be randomised. The ac-
ceptability of the intervention was further attested to by
the low drop-out rate by the end of treatment. However,
at the 6-month follow-up, there was a higher drop-out
of CBT than usual care patients (5 vs 1). Reasons for
drop-out were only available for one of the CBT patients
(they had moved city). Comparison of drop-outs be-
tween conditions showed a trend for participants with
higher scores on the VPQ, a measure of general voice-
related disability, to drop out of the SLT arm, and partic-
ipants with lower measures of anxiety, depression and
fatigue tended to drop out of the CBT arm. This could
be taken to indicate that those who were more disabled
by their voice did not feel well served by voice therapy
only, whereas those who had relatively less distress did
not see the need for the CBT treatment. However, this is
only an indicative finding, not definitive. At most it sug-
gests that stratification by vocal disability and general
distress might be a part of the design of a future study.
As indicated by treatment fidelity and protocol violations
A CBT individualised formulation was possible in 32 out
of 37 participants (86.5%). Put another way, in only five
cases was there anything like a “pure voice problem”, all
the rest had readily elicitable co-morbidities which were
amenable to explanation within the CBT model of func-
tional dysphonia. Whilst there was less monitoring of
the psychosocial aspects of voice in the usual care, the
number of patients where emotional issues became a
major part of the work was notable (9 out of 37: 24.3%).
It was also clear in these cases that the SLT drew upon
CBT techniques and principles to handle these issues.
Whilst lacking the formal formulation-based structure of
the work done in the CBT arm, the SLT’s existing coun-
selling skills had been substantially augmented by the
CBT training, in a way that could not be “undone” when
it came to providing usual care. Whilst this co-
intervention is a weakness of the trial design, it does
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indicate that the teaching of CBT skills was feasible and
acceptable to the SLT to the extent that they had be-
come internalised and changed routine clinical practice.
From the viewpoint of feasibility, these findings have
several implications. First of all, it would seem that emo-
tional issues routinely arise in, and often dominate, voice
therapy sessions. Secondly, it is clear that, whilst CBT is
a useful framework for addressing these issues, a more
general counselling approach, informed by some
evidence-based CBT principles, can also be useful, par-
ticularly in less-distressed cases. Thirdly, it is clear that
even with the best intentions, when faced with distress,
it was hard for the SLT not to turn to the newly ac-
quired set of tools. This may explain the impact of both
treatments on distress. This is an encouraging finding
from the viewpoint of the feasibility of training a
speech and language therapist in CBT, but from the
viewpoint of a future trial, it would suggest that the in-
fluence of CBT training is hard to prevent and certainly
needs to be monitored. A design where different thera-
pists deliver the CBT (experimental) and SLT (control)
interventions, i.e. a cluster randomised design with
treatment allocation at the level of the therapist, would
be a preferable design.
As indicated by therapy content
The content of the CBT sessions in many ways con-
firmed the clinical picture of these patients that has been
built up in the initial stages of intervention development.
This confirmed the utility and acceptability of a CBT
model of functional dysphonia to both patients and cli-
nicians. This model was confirmed with regard to not
only its form, but also its content. The observation of
the importance of fatigue as a co-morbid maintaining
factor was borne out. With the exception of voice, fa-
tigue was the major clinical issue in the CBT treatment
arm. This was remarkable both as a clinical finding and
as a piece of clinical work. It is highly counter-intuitive
to seek help for a voice condition and to end up setting
targets for daily exercise. If anything could be expected
to alienate patients and clinicians, it might be this, and
yet it did not. A similar situation occurred with the sleep
interventions, the second most common piece of CBT
clinical work (67.6% of patients had sleep problems). In
the pre-existing skills set of the SLT, there were the
means to deal with low mood and worry, but not fatigue
or sleep problems. The fact that they were able to iden-
tify these symptoms and engage participants in a new
treatment for it would indicate that this intervention is
highly acceptable to both clinicians and patients. Further,
it attests to the SLT’s formulation skills and to the effi-
cacy of CBT formulation in this patient group. Only a
good multi-factorial formulation could create a coherent
rationale for working on activity and sleep to treat a
voice problem. Rationale giving, and a focus on fatigue,
should be key points of any future intervention study.
Another finding of this pilot trial was the confirmation
of low mood, anxiety and perfectionism in dysphonia.
For a future trial, the content of the sessions provides
several pointers. The emphasis in training on fatigue,
sleep disruption and their treatment was shown to be
well founded. Interventions for fatigue and sleep, whilst
new to TM, were both readily taught and transmitted to
patients, and these should be a central part of a clinical
work in general and of any future trial. Behavioural acti-
vation for low mood was equally shown to be acceptable
and feasible. Cognitive interventions for worry and anx-
iety perhaps need to be more emphasised in a future
training for speech and language therapists delivering
CBT, or, given that both groups did equally well on im-
provements in anxiety, it could be that generic counsel-
ling skills are enough for dealing with worry and that
these should form part of a future training alongside
more specifically CBT techniques. Overall, the CBT
treatment content analysis provides strong evidence that
CBT was both acceptable to this patient group and this
therapist and that its further investigation in a future
trial would be feasible.
Intervention development
This study also served as a test of the viability of a par-
ticular approach to complex intervention development
based on the MRC framework [15].This was the first
study systemically to develop and pilot a cognitive be-
havioural intervention for functional dysphonia. The
process was one of repeated iteration and evolution, dur-
ing which the intervention was developed and refined as
significant novel clinical findings were added to it. This
was in some senses an unexpected by-product of the
complex intervention development process. The MRC
guidelines for intervention development suggest that the
developers build a model of the condition, but not ne-
cessarily that this model will expand the general under-
standing of the condition. However, the sustained and
structured scrutiny devoted to functional dysphonia dur-
ing the intervention development process resulted in
both a new model and in the identification of new con-
tributory factors. As Hardeman et al. [13] note, the ap-
plication of theory to intervention development allows
for knowledge of conditions to be cumulative in that
theories about mechanism can be tested and refined. To
recapitulate this development and evaluation process, a
CBT model of medically unexplained symptoms was
specified as applicable to the condition and was then
piloted as an assessment, formulation and treatment
framework in preliminary interviews and through a
small consecutive cohort study. This process helped to
elaborate the content of the model, to establish that
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fatigue and perfectionism were clinical issues and to
confirm the form of the model, i.e. that it did indeed fit
this condition. The data from this first round of evalu-
ation then contributed to both a questionnaire study and
a further round of patient interviews which confirmed
the utility of the CBT model of MUS as an assessment
and formulation structure, and the findings of fatigue
and perfectionism as precipitating and perpetuating fac-
tors. Based on this, and our increased knowledge of the
speech and language profession, the intervention, train-
ing, therapist materials, patient materials and outcome
measures were re-specified and tested in a pilot RCT of
the intervention, in which the acceptability and feasibil-
ity to both participants and professionals was examined,
through data gathering and through process observation.
Limitations
One of the chief limitations with this trial is that one
therapist delivered both interventions. It was clear from
the monitoring of this trial that there was a considerable
co-intervention effect. This was ascertained through the
clinician’s self-awareness, through the supervisory rela-
tionship and through the first author reviewing the re-
cordings of therapy sessions. However, this method of
trial monitoring is in itself a limitation, and independent
monitoring by an individual not involved in the delivery
or supervision of the intervention would be more suit-
able for a larger scale evaluation. Any future study
should employ different therapists to deliver the differ-
ent treatments. The other major limitation is that patient
acceptability was ascertained indirectly through proxies
such as drop-out and the form and content of the ther-
apy sessions. A future study should employ patient inter-
views in addition to these measures.
Conclusion
This was the development process in essence: a shuttling
back and forth between the development and feasibility/
piloting stages of the revised MRC framework. As noted
above, there is little consensus on how psychosocial in-
terventions should be modelled and piloted. We propose
that the methodology outlined above is a valuable sys-
tematic process that has allowed not only for a better
treatment but also a fuller understanding of the nature
of the condition being treated. This work needs to be
further investigated in future therapist randomised trials
that we hope this work will inform. More specifically, we
would reiterate Baker’s [12] insistence on the necessity
of training SLTs to assess and treat emotional disorders,
and we have shown that a relatively brief training in
CBT is a feasible and acceptable way of doing this [12].
These skills are easily generalised to other conditions
that SLTs routinely work with. A recently published
study by our research group has shown that training a
SLT in CBT skills to augment their treatment of swal-
lowing difficulties in head and neck cancer patients was
acceptable and feasible to both patients and the clinician
[31]. Our current intention is to use the findings from
both of these studies to design a CBT training interven-
tion for SLTs and to test its effectiveness in dealing with
the psychosocial difficulties associated with a number of
issues which commonly present to them, such as dys-
phonia and swallowing difficulties. Training health pro-
fessionals in evidence-based psychosocial clinical skills,
when conducted systemically and collaboratively, has the
potential to significantly impact on patient well-being.
The economic evaluation of this approach should be the
subject of future studies.
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